Literature DB >> 1710512

Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry.

J G Bender1, K L Unverzagt, D E Walker, W Lee, D E Van Epps, D H Smith, C C Stewart, L B To.   

Abstract

Four-color flow cytometry was used with a cocktail of antibodies to identify and isolate CD34+ hematopoietic progenitors from normal human peripheral blood (PB) and bone marrow (BM). Mature cells that did not contain colony forming cells were resolved from immature cells using antibodies for T lymphocytes (CD3), B lymphocytes (CD20), monocytes (CD14), and granulocytes (CD11b). Immature cells were subdivided based on the expression of antigens found on hematopoietic progenitors (CD34, HLA-DR, CD33, CD19, CD45, CD71, CD10, and CD7). CD34+ cells were present in the circulation in about one-tenth the concentration of BM (0.2% v 1.8%) and had a different spectrum of antigen expression. A higher proportion of PB-CD34+ cells expressed the CD33 myeloid antigen (84% v 43%) and expressed higher levels of the pan leukocyte antigen CD45 than BM-CD34+ cells. Only a small fraction of PB-CD34+ cells expressed CD71 (transferrin receptors) (17%) while 94% of BM-CD34+ expressed CD71+. The proportion of PB-CD34+ cells expressing the B-cell antigens CD19 (10%) and CD10 (3%) was not significantly different from BM-CD34+ cells (14% and 17%, respectively). Few CD34+ cells in BM (2.7%) or PB (7%) expressed the T-cell antigen CD7. CD34+ cells were found to be predominantly HLA-DR+, with a wide range of intensity. These studies show that CD34+ cells and their subsets can be identified in normal PB and that the relative frequency of these cells and their subpopulations differs in PB versus BM.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1710512

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  39 in total

1.  Efficient c-kit receptor-targeted gene transfer to primary human CD34-selected hematopoietic stem cells.

Authors:  Q Zhong; P Oliver; W Huang; D Good; V La Russa; Z Zhang; J R Cork; R W Veith; C Theodossiou; J K Kolls; P Schwarzenberger
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

2.  Neural differentiation potential of peripheral blood- and bone-marrow-derived precursor cells.

Authors:  Sangnyon Kim; Osamu Honmou; Kazunori Kato; Tadashi Nonaka; Kiyohiro Houkin; Hirufumi Hamada; Jeffery D Kocsis
Journal:  Brain Res       Date:  2006-10-24       Impact factor: 3.252

Review 3.  Autotransplants with peripheral blood stem cells and clinical results obtained in children: a review.

Authors:  K Leibundgut; A Hirt; A R Lüthy; A Tobler; H P Wagner
Journal:  Eur J Pediatr       Date:  1993-07       Impact factor: 3.183

Review 4.  Molecular characterization of CD34+ human hematopoietic progenitor cells.

Authors:  W Knapp; H Strobl; C Scheinecker; C Bello-Fernandez; O Majdic
Journal:  Ann Hematol       Date:  1995-06       Impact factor: 3.673

5.  Dielectrophoretic separation and enrichment of CD34+ cell subpopulation from bone marrow and peripheral blood stem cells.

Authors:  M S Talary; K I Mills; T Hoy; A K Burnett; R Pethig
Journal:  Med Biol Eng Comput       Date:  1995-03       Impact factor: 2.602

6.  Development of a method for direct quantification of cytomegalovirus antigenemia by flow cytometry.

Authors:  B M Imbert-Marcille; N Robillard; A S Poirier; M Coste-Burel; D Cantarovich; N Milpied; S Billaudel
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

7.  Effects of autologous stromal cells and cytokines on differentiation of equine bone marrow-derived progenitor cells.

Authors:  Ute E Schwab; Rebecca L Tallmadge; Mary Beth Matychak; M Julia B Felippe
Journal:  Am J Vet Res       Date:  2017-10       Impact factor: 1.156

8.  LW/SO cell line: a tool for studying the phenotypical characterization and commitment of hematopoietic stem cells.

Authors:  S Oez; U Trautmann; M Smetak; J Birkmann; S al salemeh; E Gebhart; W M Gallmeier
Journal:  Ann Hematol       Date:  1996-05       Impact factor: 3.673

9.  Immunohistochemical investigation of CD34 antigen in male breast carcinoma.

Authors:  S Milias; H Kalekou; M Bobos; G Karayannopoulou; D Gerasimidou; H Nenopoulou; E Panoussi; I Kostopoulos
Journal:  Clin Exp Med       Date:  2007-10-03       Impact factor: 3.984

10.  Experimental treatment of stroke in spontaneously hypertensive rats by CD34+ and CD34- cord blood cells.

Authors:  Johannes Boltze; Ina Kowalski; Kathrin Geiger; Doreen Reich; Albrecht Gunther; Christian Buhrle; Dietmar Egger; Manja Kamprad; Frank Emmrich
Journal:  Ger Med Sci       Date:  2005-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.